Response to "Clinical Relevance of CYP3A5 Genotype on Maraviroc Exposures"

Drug Metabolism and Disposition - United States
doi 10.1124/dmd.115.064188
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Related search

Tacrolimus Dose Requirement Based on the CYP3A5 Genotype in Renal Transplant Patients

Oncotarget
Oncology
2017English

Microbiology's Relevance to Clinical Medicine

BMJ
1967English

Relevance of Psychiatric Epidemiology to Clinical Psychiatry

International Review of Psychiatry
PsychiatryMental Health
1994English

Influence of CYP3A5 and Drug Transporter Polymorphisms on Imatinib Trough Concentration and Clinical Response Among Patients With Chronic Phase Chronic Myeloid Leukemia

Journal of Human Genetics
Genetics
2010English

Acclimatization Response of Rats to Discontinuous Exposures to Simulated High Altitudes

American Journal of Physiology-Legacy Content
1951English

Chemokine Receptor CCR5 Antagonist Maraviroc: Medicinal Chemistry and Clinical Applications

Current Topics in Medicinal Chemistry
MedicineDrug Discovery
2014English

Activities and Organophosphate Exposures: Response

Environmental Health Perspectives
MutagenesisPublic HealthEnvironmentalHealthToxicologyOccupational Health
2004English

Linking Genotype to Clinical Phenotype in Multiple Sclerosis

JAMA Neurology
Neurology
2016English

Performace of Genotype-MTBDR Test Directly on Clinical Specimens

Journal of Microbiology and Infectious Diseases
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy